Table 2 Variables associated with the variation in bone-mineral density (mg/cm2/year) at different sites in patients with early arthritis
From: A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
Multivariate analysis | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Lumbar spine | Total hip | UD forearm | D forearm | M forearm | ||||||
Coeff ± SD | P | Coeff ± SD | P | Coeff ± SD | P | Coeff ± SD | P | Coeff ± SD | P | |
Age (by year) | 0.3 ± 0.1 | 0.006 | 0.2 ± 0.1 | 0.026 | - | NI | - | NS | - | NI |
Female gender | - | NS | 6.1 ± 3.6 | 0.094 | 8.7 ± 4.1 | 0.032 | - | NI | - | NS |
Menopause | - | NI | - | NI | -6.4 ± 3.3 | 0.057 | -3.5 ± 1.4 | 0.01 | - | NI |
Hypertension | 6.9 ± 3.9 | 0.081 | - | NS | - | NI | - | NS | 6.7 ± 3.6 | 0.06 |
Diabetes | -19.5 ± 4.8 | <0.001 | - | NI | - | NI | - | NI | -10.3 ± 5.3 | 0.05 |
Thyroid dis. | -13.7 ± 3.9 | <0.001 | - | NI | -10.3 ± 4 | 0.01 | - | NI | - | NI |
Mean DAS28 | -0.3 ± 0.1 | 0.042 | -0.2 ± 0.1 | 0.141 | -2.3 ± 1.6 | 0.145 | - | NS | - | NI |
GC use (mg/mo) | 0.01 ± 0.02 | NS | -0.01 ± 0.02 | NS | 0.05 ± 0.02 | 0.024 | -0.001 ± 0.009 | NS | -0.05 ± 0.02 | 0.025 |